There likely will be higher interest, which is appropriate, among high-risk individuals who will benefit the most,” said Amesh Adalja, a senior scholar at the Johns Hopkins Center for Health Security.
Fall campaign for COVID-19 shots is coming, but many Americans have moved on
→
